Revenue: $1,220,000,000; YoY +25.26%; QoQ -2.94%
Gross Profit: $954,000,000; Gross Margin ~78.20%; YoY +22.31%; QoQ -3.64%
Operating Income: $438,000,000; Operating Margin ~35.90%; YoY +8.96%; QoQ -1.79%
Net Income: $134,000,000; Net Margin ~11.00%; YoY -16.77%; QoQ -0.74%
EPS Diluted: $0.21; YoY -15.38%; QoQ 0.00%
EBITDA: -$348,000,000; EBITDARatio: -0.285; Note: Reported EBITDA appears inconsistent with positive operating income and negative D&A/I&E structure; requires reconciliation in filings.
Free Cash Flow: $107,000,000; Operating Cash Flow: $116,000,000; Capital Expenditures: $9,000,000; FCF Conversion reflects positive cash generation relative to net income.
Cash, Debt, and Liquidity: Cash and cash equivalents $701,000,000; Total debt $8,701,000,000; Net debt $8,000,000,000; Long-term debt $8,421,000,000; Cash at end of period $701,000,000; Net cash from operating activities $116,000,000.
Balance Sheet Health: Total assets $16,051,000,000; Total liabilities $13,594,000,000; Total stockholders’ equity $2,457,000,000; Goodwill $10,829,000,000; Intangible assets $2,377,000,000; Total current assets $1,289,000,000; Total current liabilities $2,552,000,000.